John M. Capek, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 93,400 shares at $45.00 ($4.2M) on 2017-02-21, disclosed to the SEC on 2017-02-22.
Seasonal sale ($4.2M) by Executive Vice President — this insider has traded ABT in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2020-04-23 | $9.6M | — | Filing → |
| ABT | SELL | 2019-06-21 | $4.0M | — | Filing → |
| ABT | SELL | 2018-07-26 | $4.2M | — | Filing → |